Accurate assessment of suicidality remains one of our most difficult tasks. You will learn the latest research on risk factors for suicide. You will increase your skill in eliciting relevant information. Dangers of no-suicide contracts will be reviewed along with other pitfalls of potential liability for failing to prevent suicide.

Upon the completion of this activity, participants will be able to:

1. Improve assessment skills for suicide risk;
2. Recognize liability for completed suicide;
3. Learn liability prevention strategies

In this companion course, Dr. Schuyler will present the various formats in which he has worked with cancer patients. He will focus on what he has learned: about cancer, relating to oncologists, deference, inferences, and the most common emotional disorder seen in this group. He will contrast his work in a university setting with that of a private oncology practice. Then, he will discuss stages of cancer and its treatment that are relevant to adjustment, typical reactions seen in cancer patients, and the difficult time when treatment ends. Issues of reimbursement, will be explored along with the contrasts in both University Setting and Private Practice.

1. Develop sensitivity to the needs, habits, and styles of oncologists in approaching psychological work with cancer patients;
2. Become familiar with the challenges to the individual cancer patient provided by the different stages of the illness; and
3. Develop an approach to the patient with cancer aimed at facilitating a healthy adaptation to the illness.

Tremendous progress has been made in developing animal models for addictions, new treatments based on these models and testing these in patients with drug and alcohol dependence. We will review the most current research and state-of-the-art treatment for tobacco, alcohol, and other drugs of abuse and provide a framework for understanding current progress, limitations, and hope for the future.

By participating in this activity, attendees will be able to:

1. List major illnesses associated with obesity;
2. Discuss the epidemiology of obesity and overweight; and
3. Assess current theories, current treatment approaches-including minimally invasive surgery-and experimental approaches that have resulted from tests concluding that highly palatable, erotic and exotic foods act in the brain as a drug of abuse.

Do the media merely "reflect" the real world - as Hollywood and network executives would have us believe - or do they cause real-life problems as well? Do the media contribute to early sexual intercourse? Could the media increase teens' use of contraception? This talk will try to illuminate what we know about the impact of the media on adolescents, what we don't know, and what we need to do to find out. Several suggestions for parents and for schools will be presented.

By participating in this activity, attendees will be able to:

1. Describe the nature of current television programming for adolescents;
2. Discuss the impact of television programming on children and teens and how such effects were determined by research; and
3. Identify how the adverse effects of TV and other media can be mediated by parents and by school media literacy programs.

For far too long clinicians have viewed depression and other neuropsychiatric disorders as "brain illnesses", versus various systemic diseases like hypertension and diabetes as "body illnesses". Based on emerging evidence this dichotomy is flawed and the new concepts exemplified in the Mind/Body science have challenged us to "reconnect" brain to body. This presentation seeks to review this critical relationship and elucidate for the clinician the various systemic medical consequences associated with a "dysregulated" mind and body.

Upon the completion of this activity, participants will be able to:

1. Describe the structural and functional changes that occur during the progression of stress and mood disorders.
2. Identify the relationship of inflammation, stress and mood disorders (ie, the neurobiological correlates).

The session will provide participants with recent clinical trial data on therapeutics for the treatment of ADHD. In addition the symposium will focus on recognizing, reducing, and addressing stimulant abuse and diversion.

This activity is supported by an educational grant from Eli Lilly and Company.

This activity is sponsored by CME LLC. Veritas Institute for Medical Education, Inc. is the content provider.

You will learn predictors of violence and interview techniques in the assessment of dangerousness. Violence will be discussed in persons with various symptoms of psychosis. You will learn how to appraise "perceived intentionality," and other aspects of paranoia.

Upon the completion of this activity, participants will be able to:

1. Identify predictors of violence.
2. Learn interview techniques in the assessment of dangerousness.
3. Develop violence reduction plans.

While Substance Use Disorders have been primarily thought of as those involving chemical substances like tobacco or alcohol , more recently process addictions have been studied . Once the DSM 3 diagnostic scheme was changed to accommodate cocaine and minimize withdrawal or abstinence, gambling and sexual compulsivity have been studied and suggested to be addictions. These process addictions have much neurobiology and phenomenology in common with chemical addictions and this construct may be especially helpful in understanding the obesity epidemic and logical public health and treatment approaches.

Upon the completion of this activity, participants will be able to:

1. Review current epidemiological data on substance abuse disorders.
2. Review examples of common co-occurring disorders such as tobacco smoking and alcohol and depression.
3. List and Discuss diagnostic and treatment issues for co-occurring alcohol and tobacco-related illnesses.

Dr. Schuyler has been a pioneer in the application of cognitive therapy. A Founding Fellow of the Academy of Cognitive Therapy, his latest focus is aimed at aiding the adjustment of the patient diagnosed with cancer. In this course, he will discuss the thinking underlying the use of cognitive therapy to help the patient with severe medical illness. He will then highlight useful cognitive techniques to aid adjustment to cancer. In time set aside for questions, Dr. Schuyler will encourage clinicians to work with this needy population.

Upon completing this activity, participants will be able to:

1. To apply Cognitive Therapy's usefulness in aiding adjustment to severe illness.
2. Discuss the differences between what cognitive therapy and what it is not.
3. Utilize cognitive therapy techniques for work with cancer patients.

Psychiatrists face a daunting task every day- diagnosing patients using an imperfect diagnostic manual, limited data and external pressures. Problems with diagnosis can impact treatment outcomes and clinician liability. Tools used in forensic psychiatry may improve diagnostic validity and reliability in clinical psychiatric practice. This session will review some of the problems we face in psychiatric diagnosis as well as a practical comparison of how clinical and legal decision makers use "evidence," explore uncertainty and avoid pitfalls. The participants will identify pitfalls and potential remedies to a sample case.

Upon the completion of this activity, participants will be able to:

1. Illustrate reliability of several DSM-IV diagnoses;
2. Compare clinical and legal approaches to "the evidence" and decision making; and
3. Identify tools that can enhance clinical diagnosis and management.

Upon completion of this activity, participants will be able to:

1. Understand how the menstrual cycle and perimenopause can affect psychiatric symptoms;
2. Understand how to modify psychopharmacologic treatment for premenstrual and perimenopausal symptoms;
3. Consider other clinical interventions for premenstrual and perimenopausal psychiatric symptoms

Dementia, mania, psychosis and neuropathy are familiar manifestations of late-stage HIV/AIDS disease. Some antiretrovirals used to treat HIV are also associated with neuropsychiatric side effects.

By participating in this activity, attendees will be able to:

1. Identify neurologic and psychiatric comorbidities commonly seen in the HIV population and discuss their association with HIV infection and treatment;
2. Discuss common neuropsychiatric complications associated with HIV disease and HIV therapies and outline the strategies for managing these complications; and
3. Recognize the impact of neuropsychiatric disorders with immunologic and virologic measures of HIV disease progression.

Bipolar disorder presents significant challanges to patients and their mental health and medical treatment team. Accurate diagnosis is essential to prevent making the situation worse. Treatment is complicated with ever changing treatment needs and goals.

By participating in this session, learners will be able to:

1. More accurately diagnose and successfully manage BD;
2. Utilize current advances in the use of combination versus monotherapy to optimize relapse prevention in the acute and long-term management of BD;
3. Identify strategies to optimize individual patient management of BD including related psychiatric and medical comorbidities and improve adherance rates;
4. Understand the role of antidepressants in the treatment of BD.

With the rise in malpractice suits, it's more important than ever for mental health professionals to find out how to reduce their risk.

By participating this activity, attendees will be able to:

1. Analyze basic concepts in the law of negligence;
2. Discover common causes of action against mental health professionals; and
3. Prepare to reduce these risks in their practices.

The session will provide participants with strategies for the management of adolescents with depression.

This activity is supported by an educational grant from Forest Laboratories, Inc.

This activity is jointly sponsored by The Albert Einstein College of Medicine with Montefiore Medical Center and CME LLC.  The Institute for Continuing Healthcare Education is the content provider.

Emerging evidence compels us to take a fresh look at the treatment of depression. Quite forcefully, data directs us to view depression as a mind-body disorder. As a result, today's clinicians need to expand their treatment paradigms to be inclusive of  mind-body disruptions (not one or the other, but both). This section of the comprehensive mind-body presentation examines treatment data in detail, and offers clinicians cutting edge tools and paradigms to achieve optimum outcomes as they treat patients afflicted with depression.

Upon the completion of this activity, participants will be able to:

1. Recognize the importance of full symptomatic and functional recovery.
2. Identify the relationship of inflammation, stress and mood disorders (ie, the neurobiological correlates).
3. Discuss the significance of the biological, psychosocial, and nonpharmacological treatment options in the treatment of depression.

The session will provide participants with practical strategies for the diagnosis, treatment, and long term management of patients with schizophrenia.

12:15 - 12:45 p.m. Lunch
12:45- 2:15 p.m. Symposium

This activity is supported by an educational grant from Eli Lilly and Company.
This activity is sponsored by CME LLC. CME Outfitters is the content provider.

Emerging evidence compels us to take a fresh look at the treatment of depression. Quite forcefully, data directs us to view depression as a mind-body disorder. As a result, today's clinicians need to expand their treatment paradigms to be inclusive of  mind-body disruptions (not one or the other, but both). This section of the comprehensive mind-body presentation examines treatment data in detail, and offers clinicians cutting edge tools and paradigms to achieve optimum outcomes as they treat patients afflicted with depression.

Upon the completion of this activity, participants will be able to:

1. Recognize the importance of full symptomatic and functional recovery.
2. Identify the relationship of inflammation, stress and mood disorders (ie, the neurobiological correlates).
3. Discuss the significance of the biological, psychosocial, and nonpharmacological treatment options in the treatment of depression.

Primary care providers have less time to deal with an increasing number of health issues. When a patient presents with multiple complaints and persistent pain, primary care will attribute all the symptoms to the underlying psychologic stressors. Persistent pain worsens psychological adaptation and depression and anxiety make pain worse. Having a supportive relationship with primary care providers leads to better patient care and improved outcomes.

Upon the completion of this activity, participants will be able to:

1. Describe what primary care is looking for in referring patients with persistent pain;
2. Prepare the referring provider to care for future, similar patients; and 3) Separate the pain complaints from the psychologic issues.

Aggressive behavior is the one of the most common referral problems in child and adolescent psychiatry.

By participating in this activity, attendees will be able to:

1. List the psychiatric conditions that are associated with aggression;
2. Discuss the biological, social and psychological factors underlying the aggressive behavior; and
3. Identify the preventive interventions that will address building the therapeutic alliance with the parents and the adolescent, addressing the cultural issues, treating the comorbid psychiatric conditions etc.

Behavioral Health is constantly changing, and a large percentage of behavioral health organizations have seen a steady increase in denied claims. These health care claims which are rejected or denied lead to millions of dollars of lost revenue each year for health care organizations. Begin turning around the denial rate of your organization by attending Understanding Managed Care: Reducing Denials. This presentation is a must attend event for anyone working in the health care field. Impactful change is possible, and there are proven key steps to reducing insurance denials. Find out more about this topic and what you can do to optimize profitability, decrease costly denials, and improve your daily work load.

After completing this educational activity, participants should be able to:

1. Have a detailed understanding of the authorization and denial process that Managed Care Organizations use;
2. Identify the rules that Managed Care Organization should be following and the appeal rights; and
3. List and be able to utilize the CORE Principles to reduce denials".

Join the entire faculty of Treating the Whole Patient for an Extended Question and Answer session at the end of Day 2.

Upon the completion of this activity, participants will be able to:

1. Understand how pregnancy and the postpartum period affect the course and expression of mood disorders;
2. Understand the risks of untreated symptoms of mood disorders during pregnancy and postpartum;
3. Understand the risks of antidepressant and mood-stabilizing medications during pregnancy and postpartum, and prescribing practices that can minimize risks

Cognitive outcome in adolescents is shaped by etiological factors and the underlying neuropathology in a range of developmental and acquired brain disorders.

Upon the completion of this activity, participants will be able to:

1. Discuss the neuropsychological disorders in adolescents and their functional implications;
2. Recognize the brain-behavior relationship from the prenatal period through late adolescence within the context of typical and atypical development; and
3. Identify collaborative and consultative approaches within the context of the neuropsychological evaluation.

Fibromyalgia syndrome affects 3-5% of the population and is the second most common presenting complaint in rheumatology. Primary care providers have difficulty caring for patients with fibromyalgia due to a wide array of pain and non-pain complaints including headache, abdominal pain, irritable bladder, jaw pain, insomnia, numbness and difficulty concentrating as well as others. Many of the presenting complaints may be psychologic in nature, but the underlying disease is distinct from the presenting depressive and anxiety symptoms. Sorting the myriad complaints and providing structure can be lifesaving for patients with fibromyalgia and is best treated by those skilled in psychology.

At the end of this activity, attendees will be able to:

1. Describe the current science about the pathophysiology of fibromyalgia syndrome;
2. Help the referring provider to manage the pain and psychosocial issues; and
3. Treat patients with pharmacologic and nonpharmacologic options.

What if, for the same hour of work, you could increase your reimbursement by 20%? Or 50%? Or even 100%? It would be like that money you found in the seat cushion, wouldn't it? The reality of most practices is that with correct coding and documentation, revenue increases of this magnitude can be possible. Best of all, it can be achieved without significant new effort by you - it's just a matter of understanding the proper codes and documentation you need to support your charges.

In this session, we introduce you to the basics of Correct Coding including ICD-9 / DSM IV diagnostic code basics, Correct Procedural (CPT) coding for Behavioral Health Professionals. We will focus on basic coding techniques and practices for psychiatric and psychotherapy encounter including hints and tips to reduce denials and improve overall reimbursement.

Upon the completion of this activity, participants will be able to:

1. Understand what ICD-9, DSM IV, and CPT codes are, what they mean, and when to use them
2. Unerstand how to use Common CPT codes for Behavioral Health Management
3. Increase overall reimbursement through hints and tips they learned for improving coding

BasicNeeds (BN) is arguably the leading mental health organization in the developing world, working in 8 developing countries with new partnerships underway. Founded in the UK in 2000, BN has developed a Model for Mental Health and Development that provides a framework for and guides its work. This course describes the Model for Mental Health in the Developing world in some length and will draw parallels to US public mental health policy. Despite the enormous differences between the US and developing nations, this model is extremely relevant to US public mental health programs working with the seriously mentally ill and in resource poor locations. The course will end with a broader discussion of the future for BasicNeeds and the common challenges of sustainability faced by all mental health programs in resource poor areas.

Upon the completion of this activity, participants will be able to: . Provide a detailed description of the elements of BasicNeeds' mental health and development model . Demonstrate how these elements work in developing countries through case examples and discussion . Describe how BasicNeeds has implemented the model in different countries and the outcomes we have achieved . Describe new strategies for mental health program sustainability

Psychosocial support is an important aspect of HIV/AIDS care which enables people to function during overwhelmingly adverse circumstances and problems caused by HIV and AIDS.

By participating in this activity, attendees will be able to:

Dr. Stein examines the relationship of the two "signature injuries" experienced by Operation Enduring Freedom (OEF) and Operation Iraqi Freedom (OIF) troops, posttraumatic stress disorder (PTSD) and mild traumatic brain injury (mTBI). Studies show that a minority of individuals develop persistent emotional, somatic, and/or cognitive sequelae of traumatic exposure. Remarkably, the mechanism (emotional vs. biomechanical) or locus (head vs. other physical) of injury is a weak determinant of whether an individual develops PTSD, persistent postconcussive symptoms (PCS), or both. The frequent convergence of PTSD and PCS symptoms in military personnel is discussed, with an emphasis on studies that evaluate risk factors and outcomes. A general approach to management is discussed, as are new directions in diagnostic and therapeutic research.

Upon the completion of this activity, participants will be able to:

1. List criteria for the diagnosis of mild traumatic brain injury (mTBI);
2. Review the extent of symptom overlap between mTBI and posttraumatic stress disorder (PTSD); and
3. Describe new directions in the diagnosis and management of comorbid mTBI and PTSD